FDA Issues Warning To Sciecure Over Insomnia Drug Promo
Sciecure Pharma Inc.'s promotional materials for its insomnia drug Doral leave out important risk information and make unsupported claims that the drug is safer and more effective than the competition, according...To view the full article, register now.
Already a subscriber? Click here to view full article